Glutathione has multiple metabolic actions that are essential for cell
ular homeostasis. In spite of this important role in cellular physiolo
gy, disease states due to glutathione deficiency are not common. The p
articipation of both tissue and circulating glutathione deficiency in
disease pathogenesis is likely to be subtle and not easily defined. De
spite these difficulties, a number of inherited conditions of glutathi
one deficiency are known, and acquired ones are being identified Examp
les of the acquired deficiency state include idiopathic pulmonary fibr
osis, human immunodeficiency virus-related disease, and respiratory di
stress syndrome. Much of our current understanding of the utility of g
lutathione supplementation in states of tissue injury is derived from
biochemical, animal, and cell culture studies. In this article we will
review what is known about glutathione deficiency states and explore
strategies by which tissue glutathione levels might be maintained or i
ncreased to prevent tissue injury and disease.